Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
/in Breast Cancer, Dendritic Cells, Hypernephroma, International Publications /von 2011-10-20 / J Transl Med 2011 Oct;9:178HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-08-16 / J. Mol. Med. 2011 Dec;89(12):1231-40Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2011-06-01 / Front Biosci (Schol Ed) 2011 Jun;3:1486-99Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
/in Breast Cancer, Hyperthermia, International Publications /von 2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-9Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-97Anti-HER2 vaccines: new prospects for breast cancer therapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-312Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-02-24 / Cell. Immunol. 2010;263(1):9-21Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data
/in Breast Cancer, Hyperthermia, International Publications /von 2010-01-01 / Int J Hyperthermia 2010;26(7):612-7
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de